{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:45:04Z","timestamp":1792827904514,"version":"4.5.0"},"reference-count":98,"publisher":"American Association for Cancer Research (AACR)","issue":"7","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000884","name":"Cancer Research Institute","doi-asserted-by":"publisher","award":["CRI4828"],"award-info":[{"award-number":["CRI4828"]}],"id":[{"id":"10.13039\/100000884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5T32HL007917-26"],"award-info":[{"award-number":["5T32HL007917-26"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K99CA283008"],"award-info":[{"award-number":["K99CA283008"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA279959"],"award-info":[{"award-number":["R01CA279959"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015979","name":"Pelotonia","doi-asserted-by":"publisher","award":["23-30-73-MCAL"],"award-info":[{"award-number":["23-30-73-MCAL"]}],"id":[{"id":"10.13039\/100015979","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000043","name":"American Association for Cancer Research","doi-asserted-by":"publisher","award":["23-40-12 SPAS"],"award-info":[{"award-number":["23-40-12 SPAS"]}],"id":[{"id":"10.13039\/100000043","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014599","name":"Mark Foundation For Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014599","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Tumor-associated platelets (TAP), which are reprogrammed by tumor-derived signals to acquire immunosuppressive properties, represent an emerging mechanism of immune evasion in triple-negative breast cancer (TNBC). Although immune checkpoint inhibitors have shown promise, their efficacy is frequently limited by T-cell exhaustion and therapeutic resistance. In this study, we demonstrate that TAPs, unlike healthy circulating platelets, induce T-cell dysfunction through platelet-derived P-selectin, which engages P-selectin glycoprotein ligand 1 (PSGL-1) on T cells. This interaction promotes immunosuppressive signaling, driving T-cell exhaustion and impairing antitumor cytotoxicity. Using in vitro coculture systems and in vivo TNBC models, we show that disruption of the P-selectin\u2013PSGL-1 axis, including pharmacologic blockade with the FDA-approved anti\u2013P-selectin antibody crizanlizumab, restores T-cell function and enhances responsiveness to immune checkpoint blockade. Notably, PSGL-1, traditionally recognized for its role in leukocyte trafficking and immune regulation, is co-opted by TAPs to suppress T-cell activity, revealing a mechanism of platelet-mediated immune modulation. These findings establish TAPs as active regulators of antitumor immunity and identify the P-selectin\u2013PSGL-1 axis as a therapeutically actionable target to overcome resistance to immunotherapy in TNBC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Tumor-associated platelets help TNBCs evade immune attack by suppressing T-cell function through P-selectin signaling. Blocking this pathway with crizanlizumab restores antitumor immunity and enhances response to immunotherapy, identifying a promising new combination treatment strategy for patients with this aggressive form of breast cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-26-0187","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:10:08Z","timestamp":1781637008000},"page":"1640-1655","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Tumor-Associated Platelets Suppress T-cell Function and Promote Immune Evasion in TNBC via the P-selectin\/P-selectin Glycoprotein Ligand 1 Pathway"],"prefix":"10.1158","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3523-7150","authenticated-orcid":false,"given":"Margaret R.","family":"Smith-Oliver","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04b6nzv94","id-type":"ROR","asserted-by":"publisher"}],"name":"Brigham and Women\u2019s Hospital 1 Division of Hematology, Department of Medicine, , Boston, Massachusetts."},{"name":"2Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2437-6136","authenticated-orcid":false,"given":"Deepa","family":"Gautam","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04b6nzv94","id-type":"ROR","asserted-by":"publisher"}],"name":"Brigham and Women\u2019s Hospital 1 Division of Hematology, Department of Medicine, , Boston, Massachusetts."},{"name":"2Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8287-8096","authenticated-orcid":false,"given":"Grace C.","family":"Petrarca","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04b6nzv94","id-type":"ROR","asserted-by":"publisher"}],"name":"Brigham and Women\u2019s Hospital 1 Division of Hematology, Department of Medicine, , Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0879-0553","authenticated-orcid":false,"given":"Megan E.","family":"Sullivan","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04b6nzv94","id-type":"ROR","asserted-by":"publisher"}],"name":"Brigham and Women\u2019s Hospital 1 Division of Hematology, Department of Medicine, , Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3035-4529","authenticated-orcid":false,"given":"Emily M.","family":"Clarke","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04b6nzv94","id-type":"ROR","asserted-by":"publisher"}],"name":"Brigham and Women\u2019s Hospital 1 Division of Hematology, Department of Medicine, , Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6586-5502","authenticated-orcid":false,"given":"Giovanni","family":"Goggi","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04b6nzv94","id-type":"ROR","asserted-by":"publisher"}],"name":"Brigham and Women\u2019s Hospital 1 Division of Hematology, Department of Medicine, , Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5451-7003","authenticated-orcid":false,"given":"Milos","family":"Spasic","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04b6nzv94","id-type":"ROR","asserted-by":"publisher"}],"name":"Brigham and Women\u2019s Hospital 1 Division of Hematology, Department of Medicine, , Boston, Massachusetts."},{"name":"2Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5165-3661","authenticated-orcid":false,"given":"Natalie","family":"Kane","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00dvg7y05","id-type":"ROR","asserted-by":"publisher"}],"name":"Boston Children\u2019s Hospital 3 Division of Newborn Medicine, , Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9151-4386","authenticated-orcid":false,"given":"Jared","family":"Brown","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02jzgtq86","id-type":"ROR","asserted-by":"publisher"}],"name":"Dana-Farber Cancer Institute 4 Department of Data Science, , Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1100-8409","authenticated-orcid":false,"given":"Harvey G.","family":"Roweth","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05v62cm79","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Reading 5 School of Biological Sciences, , Reading, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5182-7575","authenticated-orcid":false,"given":"Joanna","family":"Baginska","sequence":"additional","affiliation":[{"name":"2Harvard Medical School, Boston, Massachusetts."},{"name":"6Dana Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5989-6636","authenticated-orcid":false,"given":"Ana C.","family":"Garrido-Castro","sequence":"additional","affiliation":[{"name":"2Harvard Medical School, Boston, Massachusetts."},{"id":[{"id":"https:\/\/ror.org\/02jzgtq86","id-type":"ROR","asserted-by":"publisher"}],"name":"Dana-Farber Cancer Institute 7 Department of Medical Oncology, , Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1230-504X","authenticated-orcid":false,"given":"Patricia","family":"Davenport","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00dvg7y05","id-type":"ROR","asserted-by":"publisher"}],"name":"Boston Children\u2019s Hospital 3 Division of Newborn Medicine, , Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5111-5903","authenticated-orcid":false,"given":"Sandra S.","family":"McAllister","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04b6nzv94","id-type":"ROR","asserted-by":"publisher"}],"name":"Brigham and Women\u2019s Hospital 1 Division of Hematology, Department of Medicine, , Boston, Massachusetts."},{"name":"2Harvard Medical School, Boston, Massachusetts."},{"name":"8Broad Institute of Harvard and MIT, Cambridge, Massachusetts."},{"name":"9Harvard Stem Cell Institute, Cambridge, Massachusetts."},{"name":"10Dana-Farber\/Harvard Cancer Center, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1916-047X","authenticated-orcid":false,"given":"Elisabeth M.","family":"Battinelli","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04b6nzv94","id-type":"ROR","asserted-by":"publisher"}],"name":"Brigham and Women\u2019s Hospital 1 Division of Hematology, Department of Medicine, , Boston, Massachusetts."},{"name":"2Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"2026071006013614700_bib1","doi-asserted-by":"publisher","first-page":"e36905","DOI":"10.1097\/MD.0000000000036905","article-title":"Breast cancer: a review of risk factors and diagnosis","volume":"103","author":"Obeagu","year":"2024","journal-title":"Medicine"},{"key":"2026071006013614700_bib2","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1182\/blood.2023022928","article-title":"Procoagulant platelets promote immune evasion in triple-negative breast cancer","volume":"144","author":"Schaubaecher","year":"2024","journal-title":"Blood"},{"key":"2026071006013614700_bib3","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1158\/1078-0432.CCR-18-2782","article-title":"Impact of breast cancer subtypes on prognosis of women with operable invasive breast cancer: a population-based study using SEER database","volume":"25","author":"Hwang","year":"2019","journal-title":"Clin Cancer Res"},{"key":"2026071006013614700_bib4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer\u2013immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"2026071006013614700_bib5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/cncy.21951","article-title":"Biomarkers for immune checkpoint inhibitors: the importance of tumor topography and the challenges to cytopathology","volume":"126","author":"Clark","year":"2018","journal-title":"Cancer Cytopathol"},{"key":"2026071006013614700_bib6","doi-asserted-by":"publisher","first-page":"351959","DOI":"10.1155\/2014\/351959","article-title":"Tumor microenvironment: a new treatment target for cancer","volume":"2014","author":"Tsai","year":"2014","journal-title":"ISRN Biochem"},{"key":"2026071006013614700_bib7","doi-asserted-by":"publisher","first-page":"104683","DOI":"10.1016\/j.phrs.2020.104683","article-title":"Tumor microenvironment: challenges and opportunities in targeting metastasis of triple negative breast cancer","volume":"153","author":"Deepak","year":"2020","journal-title":"Pharmacol Res"},{"key":"2026071006013614700_bib8","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1200\/OP.22.00483","article-title":"Role of immunotherapy in breast cancer","volume":"19","author":"Jacob","year":"2023","journal-title":"JCO Oncol Pract"},{"key":"2026071006013614700_bib9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41523-023-00508-3","article-title":"Immunotherapy in breast cancer: an overview of current strategies and perspectives","volume":"9","author":"Debien","year":"2023","journal-title":"NPJ Breast Cancer"},{"key":"2026071006013614700_bib10","doi-asserted-by":"publisher","first-page":"102831","DOI":"10.1016\/j.ctrv.2024.102831","article-title":"The landscape of combining immune checkpoint inhibitors with novel therapies: secret alliances against breast cancer","volume":"130","author":"Rebaudi","year":"2024","journal-title":"Cancer Treat Rev"},{"key":"2026071006013614700_bib11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13045-024-01649-z","article-title":"Current and future immunotherapy for breast cancer","volume":"17","author":"Heater","year":"2024","journal-title":"J Hematol Oncol"},{"key":"2026071006013614700_bib12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0191-1","article-title":"Immune checkpoint inhibitors: recent progress and potential biomarkers","volume":"50","author":"Darvin","year":"2018","journal-title":"Exp Mol Med"},{"key":"2026071006013614700_bib13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"2026071006013614700_bib14","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1016\/j.clbc.2023.10.011","article-title":"Analysis of immune resistance mechanisms in TNBC: dual effects inside and outside the tumor","volume":"24","author":"Xu","year":"2024","journal-title":"Clin Breast Cancer"},{"key":"2026071006013614700_bib15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s43046-025-00295-x","article-title":"Immunotherapy for triple-negative breast cancer: current trends and future prospects","volume":"37","author":"Essalihi","year":"2025","journal-title":"J Egypt Natl Canc Inst"},{"key":"2026071006013614700_bib16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13058-022-01563-7","article-title":"High platelet-to-lymphocyte ratios in triple-negative breast cancer associates with immunosuppressive status of TILs","volume":"24","author":"Onagi","year":"2022","journal-title":"Breast Cancer Res"},{"key":"2026071006013614700_bib17","doi-asserted-by":"publisher","first-page":"6069","DOI":"10.2147\/CMAR.S257727","article-title":"Elevated platelet count predicts poor prognosis in breast cancer patients with supraclavicular lymph node metastasis","volume":"12","author":"Liu","year":"2020","journal-title":"Cancer Manag Res"},{"key":"2026071006013614700_bib18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40164-022-00272-3","article-title":"Trends in platelet count among cancer patients","volume":"11","author":"Giannakeas","year":"2022","journal-title":"Exp Hematol Oncol"},{"key":"2026071006013614700_bib19","doi-asserted-by":"publisher","first-page":"100015","DOI":"10.1016\/j.bvth.2024.100015","article-title":"Targeting the P-selectin\/PSGL-1 pathway: discovery of disease-modifying therapeutics for disorders of thromboinflammation","volume":"1","author":"Escopy","year":"2024","journal-title":"Blood Vessel Thromb Hemost"},{"key":"2026071006013614700_bib20","doi-asserted-by":"publisher","first-page":"6138145","DOI":"10.1155\/2017\/6138145","article-title":"The interaction of selectins and PSGL-1 as a key component in thrombus formation and cancer progression","volume":"2017","author":"Kappelmayer","year":"2017","journal-title":"Biomed Res Int"},{"key":"2026071006013614700_bib21","doi-asserted-by":"publisher","first-page":"384685","DOI":"10.1155\/2012\/384685","article-title":"Crosstalk between platelets and the immune system: old systems with new discoveries","volume":"2012","author":"Li","year":"2012","journal-title":"Adv Hematol"},{"key":"2026071006013614700_bib22","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1158\/2159-8290.CD-12-0216","article-title":"Identification of luminal breast cancers that establish a tumor-supportive macroenvironment defined by proangiogenic platelets and bone marrow-derived cells","volume":"2","author":"Kuznetsov","year":"2012","journal-title":"Cancer Discov"},{"key":"2026071006013614700_bib23","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1182\/blood-2011-02-334524","article-title":"Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis","volume":"118","author":"Battinelli","year":"2011","journal-title":"Blood"},{"key":"2026071006013614700_bib24","doi-asserted-by":"publisher","first-page":"5668","DOI":"10.1182\/bloodadvances.2021006120","article-title":"Platelets upregulate tumor cell programmed death ligand 1 in an epidermal growth factor receptor-dependent manner in vitro","volume":"6","author":"Guo","year":"2022","journal-title":"Blood Adv"},{"key":"2026071006013614700_bib25","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1182\/bloodadvances.2018026161","article-title":"Aspirin inhibits platelets from reprogramming breast tumor cells and promoting metastasis","volume":"3","author":"Johnson","year":"2019","journal-title":"Blood Adv"},{"key":"2026071006013614700_bib26","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1186\/s40001-023-01342-w","article-title":"The critical role of platelet in cancer progression and metastasis","volume":"28","author":"Zhou","year":"2023","journal-title":"Eur J Med Res"},{"key":"2026071006013614700_bib27","doi-asserted-by":"publisher","first-page":"e350","DOI":"10.1002\/mco2.350","article-title":"The role of platelets in the regulation of tumor growth and metastasis: the mechanisms and targeted therapy","volume":"4","author":"Liao","year":"2023","journal-title":"MedComm (2020)"},{"key":"2026071006013614700_bib28","doi-asserted-by":"publisher","first-page":"7005","DOI":"10.1038\/s41467-021-27303-7","article-title":"Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancer","volume":"12","author":"Hinterleitner","year":"2021","journal-title":"Nat Commun"},{"key":"2026071006013614700_bib29","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1083\/jcb.101.3.880","article-title":"A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation","volume":"101","author":"Stenberg","year":"1985","journal-title":"J Cell Biol"},{"key":"2026071006013614700_bib30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3109\/15419069409014198","article-title":"Expression of P-selectin on endothelial cells is upregulated by LPS and TNF-alpha in vivo","volume":"2","author":"Gotsch","year":"1994","journal-title":"Cell Adhes Commun"},{"key":"2026071006013614700_bib31","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1084\/jem.190.12.1769","article-title":"Targeted gene disruption demonstrates that P-selectin glycoprotein ligand 1 (PSGL-1) is required for P-selectin-mediated but not E-selectin-mediated neutrophil rolling and migration","volume":"190","author":"Yang","year":"1999","journal-title":"J Exp Med"},{"key":"2026071006013614700_bib32","doi-asserted-by":"publisher","first-page":"6584","DOI":"10.18632\/oncotarget.3164","article-title":"P-selectin-mediated platelet adhesion promotes tumor growth","volume":"6","author":"Qi","year":"2015","journal-title":"Oncotarget"},{"key":"2026071006013614700_bib33","doi-asserted-by":"publisher","first-page":"1546157","DOI":"10.3389\/fphar.2025.1546157","article-title":"1,8-Cineole inhibits platelet-leukocyte aggregate formation by reducing P-selectin expression","volume":"16","author":"Petry","year":"2025","journal-title":"Front Pharmacol"},{"key":"2026071006013614700_bib34","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1161\/01.ATV.0000149675.83552.83","article-title":"Sulfatides activate platelets through P-selectin and enhance platelet and platelet-leukocyte aggregation","volume":"25","author":"Merten","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026071006013614700_bib35","doi-asserted-by":"publisher","first-page":"9325","DOI":"10.1073\/pnas.95.16.9325","article-title":"P-selectin deficiency attenuates tumor growth and metastasis","volume":"95","author":"Kim","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026071006013614700_bib36","doi-asserted-by":"publisher","first-page":"4662","DOI":"10.1158\/0008-5472.CAN-11-4010","article-title":"Platelets and P-selectin control tumor cell metastasis in an organ-specific manner and independently of NK cells","volume":"72","author":"Coupland","year":"2012","journal-title":"Cancer Res"},{"key":"2026071006013614700_bib37","doi-asserted-by":"publisher","first-page":"e25281","DOI":"10.7554\/eLife.25281","article-title":"Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcome","volume":"6","author":"Ferber","year":"2017","journal-title":"Elife"},{"key":"2026071006013614700_bib38","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jconrel.2016.03.024","article-title":"Assessing the therapeutic efficacy of VEGFR-1-targeted polymer drug conjugates in mouse tumor models","volume":"229","author":"Shamay","year":"2016","journal-title":"J Control Release"},{"key":"2026071006013614700_bib39","doi-asserted-by":"publisher","first-page":"8509","DOI":"10.1002\/jcp.27782","article-title":"CD8+ cytotoxic T lymphocytes in cancer immunotherapy: a review","volume":"234","author":"Farhood","year":"2019","journal-title":"J Cell Physiol"},{"key":"2026071006013614700_bib40","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1146\/annurev.immunol.15.1.297","article-title":"Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches","volume":"15","author":"Constant","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"2026071006013614700_bib41","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4 T cell populations (*)","volume":"28","author":"Zhu","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"2026071006013614700_bib42","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1111\/jth.12612","article-title":"Platelets provoke distinct dynamics of immune responses by differentially regulating CD4+ T-cell proliferation","volume":"12","author":"Zhu","year":"2014","journal-title":"J Thromb Haemost"},{"key":"2026071006013614700_bib43","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1182\/bloodadvances.2016001453","article-title":"TGF-\u03b21 along with other platelet contents augments Treg cells to suppress anti-FVIII immune responses in hemophilia A mice","volume":"1","author":"Haribhai","year":"2016","journal-title":"Blood Adv"},{"key":"2026071006013614700_bib44","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.it.2017.02.002","article-title":"PSGL-1: a new player in the immune checkpoint landscape","volume":"38","author":"Tinoco","year":"2017","journal-title":"Trends Immunol"},{"key":"2026071006013614700_bib45","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s40265-019-01254-2","article-title":"Crizanlizumab: first approval","volume":"80","author":"Blair","year":"2020","journal-title":"Drugs"},{"key":"2026071006013614700_bib46","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1056\/NEJMoa1611770","article-title":"Crizanlizumab for the prevention of pain crises in sickle cell disease","volume":"376","author":"Ataga","year":"2017","journal-title":"N Engl J Med"},{"key":"2026071006013614700_bib47","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/s0039-6109(05)70443-6","article-title":"Breast cancer in men","volume":"76","author":"Donegan","year":"1996","journal-title":"Surg Clin North Am"},{"key":"2026071006013614700_bib48","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/BF00300234","article-title":"Determination of subcutaneous tumor size in athymic (nude) mice","volume":"24","author":"Tomayko","year":"1989","journal-title":"Cancer Chemother Pharmacol"},{"issue":"7_Supplement","key":"2026071006013614700_bib49","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1158\/1538-7445.am2023-623","article-title":"Abstract 623: immunological aging slows triple-negative breast cancer progression and impedes response to therapy","volume":"83","author":"Spasic","year":"2023","journal-title":"Cancer Res"},{"key":"2026071006013614700_bib50","doi-asserted-by":"publisher","first-page":"e14526","DOI":"10.1371\/journal.pone.0014526","article-title":"Enhanced platelet activation mediates the accelerated angiogenic switch in mice lacking histidine-rich glycoprotein","volume":"6","author":"Ringvall","year":"2011","journal-title":"PLoS One"},{"key":"2026071006013614700_bib51","doi-asserted-by":"publisher","first-page":"103371","DOI":"10.1016\/j.rpth.2026.103371","article-title":"Characterizing mouse platelet heterogeneity across diverse disease models using spectral flow cytometry and high-dimensional analysis","volume":"10","author":"Gautam","year":"2026","journal-title":"Res Pract Thromb Haemost"},{"key":"2026071006013614700_bib52","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1158\/0008-5472.CAN-24-0658","article-title":"Targeting NTRK1 enhances immune checkpoint inhibitor efficacy in NTRK1 wild-type non-small cell lung cancer","volume":"84","author":"Smith","year":"2024","journal-title":"Cancer Res"},{"key":"2026071006013614700_bib53","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1161\/ATVBAHA.116.308791","article-title":"Tamoxifen directly inhibits platelet angiogenic potential and platelet-mediated metastasis","volume":"37","author":"Johnson","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026071006013614700_bib54","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1158\/2326-6066.CIR-14-0150","article-title":"Galectin-3 shapes antitumor immune responses by suppressing CD8+ T cells via LAG-3 and inhibiting expansion of plasmacytoid dendritic cells","volume":"3","author":"Kouo","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"2026071006013614700_bib55","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/nature13848","article-title":"CEACAM1 regulates TIM-3-mediated tolerance and exhaustion","volume":"517","author":"Huang","year":"2015","journal-title":"Nature"},{"key":"2026071006013614700_bib56","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1046\/j.1365-2567.1999.00888.x","article-title":"Interaction of CTLA-4 (CD152) with CD80 or CD86 inhibits human T-cell activation","volume":"98","author":"Vandenborre","year":"1999","journal-title":"Immunology"},{"key":"2026071006013614700_bib57","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3389\/fimmu.2013.00321","article-title":"MHC class II polymorphisms, autoreactive T-cells, and autoimmunity","volume":"4","author":"Tsai","year":"2013","journal-title":"Front Immunol"},{"key":"2026071006013614700_bib58","first-page":"727","article-title":"PD-1\/PD-L1 pathway: current researches in cancer","volume":"10","author":"Han","year":"2020","journal-title":"Am J Cancer Res"},{"key":"2026071006013614700_bib59","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/s41467-021-21099-2","article-title":"Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy","volume":"12","author":"Yang","year":"2021","journal-title":"Nat Commun"},{"key":"2026071006013614700_bib60","doi-asserted-by":"publisher","first-page":"103502","DOI":"10.1016\/j.critrevonc.2021.103502","article-title":"Platelet-mediated tumor metastasis mechanism and the role of cell adhesion molecules","volume":"167","author":"Liu","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"2026071006013614700_bib61","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1074\/jbc.REV119.007759","article-title":"Cell adhesion in cancer: beyond the migration of single cells","volume":"295","author":"Janiszewska","year":"2020","journal-title":"J Biol Chem"},{"key":"2026071006013614700_bib62","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/j.thromres.2021.12.027","article-title":"The role of P-selectin in cancer-associated thrombosis and beyond","volume":"213","author":"Yeini","year":"2022","journal-title":"Thromb Res"},{"issue":"11 Suppl","key":"2026071006013614700_bib63","first-page":"S97","article-title":"Role of PSGL-1 binding to selectins in leukocyte recruitment","volume":"100","author":"McEver","year":"1997","journal-title":"J Clin Invest"},{"key":"2026071006013614700_bib64","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.lfs.2015.02.025","article-title":"P-selectin enhances growth and metastasis of mouse mammary tumors by promoting regulatory T cell infiltration into the tumors","volume":"131","author":"Nasti","year":"2015","journal-title":"Life Sci"},{"key":"2026071006013614700_bib65","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-11-1872","article-title":"Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells","volume":"72","author":"Placke","year":"2012","journal-title":"Cancer Res"},{"key":"2026071006013614700_bib66","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","article-title":"Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis","volume":"20","author":"Labelle","year":"2011","journal-title":"Cancer Cell"},{"key":"2026071006013614700_bib67","doi-asserted-by":"publisher","first-page":"849","DOI":"10.2147\/JPR.S278285","article-title":"P-selectin blockade in the treatment of painful vaso-occlusive crises in sickle cell disease: a spotlight on crizanlizumab","volume":"14","author":"Karki","year":"2021","journal-title":"J Pain Res"},{"key":"2026071006013614700_bib68","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/jleuko\/qiae048","article-title":"Increased platelet-CD8+ T-cell aggregates displaying high activation, exhaustion, and tendency to death correlate with disease progression in people with HIV-1","volume":"116","author":"Wu","year":"2024","journal-title":"J Leukoc Biol"},{"key":"2026071006013614700_bib69","doi-asserted-by":"publisher","first-page":"799124","DOI":"10.3389\/fimmu.2021.799124","article-title":"Increased platelet-CD4+ T cell aggregates are correlated with HIV-1 permissiveness and CD4+ T cell loss","volume":"12","author":"Dai","year":"2021","journal-title":"Front Immunol"},{"key":"2026071006013614700_bib70","article-title":"Microbubbles coated with anti-P-selectin antibody RB40.34","volume-title":"Molecular imaging and contrast agent database (MICAD) [Internet]","author":"Leung","year":"2006"},{"key":"2026071006013614700_bib71","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.immuni.2016.04.015","article-title":"PSGL-1 is an immune checkpoint regulator that promotes T cell exhaustion","volume":"44","author":"Tinoco","year":"2016","journal-title":"Immunity"},{"key":"2026071006013614700_bib72","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1182\/blood.V88.8.3010.bloodjournal8883010","article-title":"P-selectin glycoprotein ligand-1 is broadly expressed in cells of myeloid, lymphoid, and dendritic lineage and in some nonhematopoietic cells","volume":"88","author":"Laszik","year":"1996","journal-title":"Blood"},{"key":"2026071006013614700_bib73","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12935-025-03877-w","article-title":"The role of platelets in tumor immune evasion and metastasis: mechanisms and therapeutic implications","volume":"25","author":"Gan","year":"2025","journal-title":"Cancer Cell Int"},{"key":"2026071006013614700_bib74","doi-asserted-by":"publisher","first-page":"104380","DOI":"10.1016\/j.critrevonc.2024.104380","article-title":"Interactions between platelets and the cancer immune microenvironment","volume":"199","author":"Tuerhong","year":"2024","journal-title":"Crit Rev Oncol Hematol"},{"key":"2026071006013614700_bib75","doi-asserted-by":"publisher","first-page":"e175320","DOI":"10.1172\/jci.insight.175320","article-title":"Evaluating immunotherapeutic outcomes in triple-negative breast cancer with a cholesterol radiotracer in mice","volume":"9","author":"Ciavattone","year":"2024","journal-title":"JCI Insight"},{"key":"2026071006013614700_bib76","doi-asserted-by":"publisher","first-page":"437","DOI":"10.7555\/JBR.29.20150121","article-title":"Platelets in hemostasis and thrombosis: novel mechanisms of fibrinogen-independent platelet aggregation and fibronectin-mediated protein wave of hemostasis","volume":"29","author":"Hou","year":"2015","journal-title":"J Biomed Res"},{"key":"2026071006013614700_bib77","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40364-025-00742-w","article-title":"The role of platelets in cancer: from their influence on tumor progression to their potential use in liquid biopsy","volume":"13","author":"Morales-Pacheco","year":"2025","journal-title":"Biomarker Res"},{"key":"2026071006013614700_bib78","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/MOH.0000000000000852","article-title":"Platelets and circulating (tumor) cells: partners in promoting metastatic cancer","volume":"32","author":"Gautam","year":"2025","journal-title":"Curr Opin Hematol"},{"key":"2026071006013614700_bib79","doi-asserted-by":"publisher","first-page":"4289","DOI":"10.1074\/jbc.271.8.4289","article-title":"Structure-function analysis of P-selectin-sialyl LewisX binding interactions. Mutagenic alteration of ligand binding specificity","volume":"271","author":"Revelle","year":"1996","journal-title":"J Biol Chem"},{"key":"2026071006013614700_bib80","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1177\/87551225211008460","article-title":"Crizanlizumab for the prevention of vaso-occlusive pain crises in sickle cell disease","volume":"37","author":"Stevens","year":"2021","journal-title":"J Pharm Technol"},{"key":"2026071006013614700_bib81","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/s41586-024-08451-4","article-title":"Precursors of exhausted T cells are pre-emptively formed in acute infection","volume":"640","author":"Chu","year":"2025","journal-title":"Nature"},{"key":"2026071006013614700_bib82","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s42003-023-04631-6","article-title":"CD83 expression characterizes precursor exhausted T cell population","volume":"6","author":"Wu","year":"2023","journal-title":"Commun Biol"},{"key":"2026071006013614700_bib83","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.immuni.2020.04.014","article-title":"Developmental relationships of four exhausted CD8+ T cell subsets reveals underlying transcriptional and epigenetic landscape control mechanisms","volume":"52","author":"Beltra","year":"2020","journal-title":"Immunity"},{"key":"2026071006013614700_bib84","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/s41590-020-0760-z","article-title":"Early precursor T cells establish and propagate T cell exhaustion in chronic infection","volume":"21","author":"Utzschneider","year":"2020","journal-title":"Nat Immunol"},{"key":"2026071006013614700_bib85","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.immuni.2019.09.013","article-title":"TCF-1-centered transcriptional network drives an effector versus exhausted CD8 T cell-fate decision","volume":"51","author":"Chen","year":"2019","journal-title":"Immunity"},{"key":"2026071006013614700_bib86","doi-asserted-by":"publisher","first-page":"6990","DOI":"10.1016\/j.vaccine.2006.04.043","article-title":"Effect of allergen-specific immunotherapy on platelet secretory activity in patients with grass-pollen allergy","volume":"24","author":"Kasperska-Zajac","year":"2006","journal-title":"Vaccine"},{"key":"2026071006013614700_bib87","doi-asserted-by":"publisher","first-page":"103773","DOI":"10.1016\/j.critrevonc.2022.103773","article-title":"Tumor infiltrating lymphocytes (TILs) as a predictive biomarker of response to checkpoint blockers in solid tumors: a systematic review","volume":"177","author":"Presti","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"key":"2026071006013614700_bib88","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3390\/cancers15030767","article-title":"Tumor infiltrating lymphocytes across breast cancer subtypes: current issues for biomarker assessment","volume":"15","author":"Valenza","year":"2023","journal-title":"Cancers (Basel)"},{"key":"2026071006013614700_bib89","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1038\/s41388-020-01611-6","article-title":"Is PD-L1 a consistent biomarker for anti-PD-1 therapy? The model of balstilimab in a virally-driven tumor","volume":"40","author":"Grossman","year":"2021","journal-title":"Oncogene"},{"key":"2026071006013614700_bib90","doi-asserted-by":"publisher","first-page":"5121","DOI":"10.1007\/s10238-023-01190-2","article-title":"Diagnostic biopsy does not accurately reflect the PD-L1 expression in triple-negative breast cancer","volume":"23","author":"Zdrenka","year":"2023","journal-title":"Clin Exp Med"},{"key":"2026071006013614700_bib91","doi-asserted-by":"publisher","first-page":"939089","DOI":"10.3389\/fonc.2022.939089","article-title":"Emerging roles of platelets in cancer biology and their potential as therapeutic targets","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"2026071006013614700_bib92","doi-asserted-by":"publisher","first-page":"217044","DOI":"10.1016\/j.canlet.2024.217044","article-title":"The use of platelets as a clinical tool in oncology: opportunities and challenges","volume":"607","author":"Bravaccini","year":"2024","journal-title":"Cancer Lett"},{"key":"2026071006013614700_bib93","doi-asserted-by":"publisher","first-page":"447","DOI":"10.34172\/aim.2023.68","article-title":"Emerging role of tumor-educated platelets as a new liquid biopsy tool for colorectal cancer","volume":"26","author":"Razzaghi","year":"2023","journal-title":"Arch Iran Med"},{"key":"2026071006013614700_bib94","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/s41586-025-08626-7","article-title":"Aspirin prevents metastasis by limiting platelet TXA2 suppression of T cell immunity","volume":"640","author":"Yang","year":"2025","journal-title":"Nature"},{"key":"2026071006013614700_bib95","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1093\/cvr\/cvv154","article-title":"Selectins: initiators of leucocyte adhesion and signalling at the vascular wall","volume":"107","author":"McEver","year":"2015","journal-title":"Cardiovasc Res"},{"key":"2026071006013614700_bib96","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3389\/fimmu.2019.01068","article-title":"L-selectin: a major regulator of leukocyte adhesion, migration and signaling","volume":"10","author":"Ivetic","year":"2019","journal-title":"Front Immunol"},{"key":"2026071006013614700_bib97","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1038\/s41467-024-47516-w","article-title":"Platelets favor the outgrowth of established metastases","volume":"15","author":"Garcia-Leon","year":"2024","journal-title":"Nat Commun"},{"key":"2026071006013614700_bib98","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrc3004","article-title":"Contribution of platelets to tumour metastasis","volume":"11","author":"Gay","year":"2011","journal-title":"Nat Rev Cancer"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-26-0187\/3804001\/crc-26-0187.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/7\/1640\/3810235\/crc-26-0187.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/7\/1640\/3810235\/crc-26-0187.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T10:01:44Z","timestamp":1783677704000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/6\/7\/1640\/786395\/Tumor-Associated-Platelets-Suppress-T-cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":98,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-26-0187","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.32956408","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32956438","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32956405","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32956426","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32956429","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32956417","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32956450","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32956423","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32956444","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32956411","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32956414","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32956447","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32956402","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32956435","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32956396","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32956441","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32956432","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32956399","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32956420","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.8587186","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]}}}